2004至2011年口咽鳞状细胞癌生存率的亚部位差异
该回顾性队列分析利用监测、流行病学和最终结果(SEER)项目数据,纳入2004至2011年无远处转移的15,299例舌根与扁桃体窝鳞状细胞癌患者,比较两亚部位的总生存与疾病特异性生存。结果显示扁桃体窝癌的总生存优于舌根癌(P<.001),按分期分层后仍更优,疾病特异性生存亦倾向扁桃体窝更佳。
要点
- 全分期合并时扁桃体窝癌总生存优于舌根癌(P<.001)。
- 按分期分层后扁桃体窝癌总生存仍优于舌根癌。
- 多因素校正后扁桃体窝癌总生存风险比优于舌根癌(1期P=.041;2期P=.006;3和4期P<.001)。
核心结论
- 在这一大型现代队列中,扁桃体窝癌的总生存和疾病特异性生存均优于舌根癌。
- 仍需进一步研究评估在现代治疗背景下影响扁桃体窝与舌根生存差异的因素。
研究设计与样本
- 回顾性队列分析,利用监测、流行病学和最终结果(SEER)项目数据。
- 纳入2004至2011年无远处转移的舌根与扁桃体窝鳞状细胞癌患者15,299例。
主要发现
- 队列中舌根癌7,220例(47.2%),扁桃体窝癌8,079例(52.8%)。
- 全分期合并的总生存 favoring 扁桃体窝(P<.001),按分期分层后仍更优。
- 多因素校正年龄、性别、种族和治疗后,扁桃体窝癌总生存风险比优于舌根癌:1期P=.041,2期P=.006,3和4期P<.001。
- 疾病特异性生存亦倾向扁桃体窝癌结局更优。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To evaluate subsite-specific differences in survival between squamous cell carcinomas of the base of tongue and tonsillar fossa in a modern cohort likely to have been treated with intensity-modulated radiation therapy, chemotherapy for stage III and IV, and have had a high incidence of human papillomavirus-associated tumors. STUDY DESIGN: Retrospective cohort analysis utilizing data from the Surveillance, Epidemiology, and End Results program of patients with base of tongue and tonsillar fossa squamous cell carcinoma from 2004 to 2011. METHODS: The cohort included 15,299 primary base of tongue and tonsillar fossa squamous cell carcinoma patients without distant metastases treated between 2004 and 2011. Subsite differences in overall survival and disease-specific survival were examined with Kaplan-Meier curves. Multivariate cox proportional hazard ratios were estimated for overall and disease-specific survival. RESULTS: The cohort included 7,220 (47.2%) base of tongue and 8,079 (52.8%) tonsillar fossa squamous cell carcinoma patients. Overall survival with all stages combined favored tonsillar fossa (P < .001) and remained superior when stratified by stage. In multivariate analyses adjusted for age, gender, race, and treatment, the hazard ratio for overall survival was superior for tonsillar fossa tumors compared to base of tongue tumors for all stages (stage 1, P = .041; stage 2, P = .006; stages 3 and 4, P < .001). Disease-specific survival also favored improved outcomes for tonsillar fossa. CONCLUSIONS: In this large modern cohort, overall and disease-specific survival favored outcomes in tonsillar fossa compared with base of tongue. Further study is required to evaluate factors that influence survival differences between tonsillar fossa and base of tongue despite modern therapy. LEVEL OF EVIDENCE: 4 Laryngoscope, 127:1087-1092, 2017.
引用
- Platek ME, Jayaprakash V, Gupta V, et al. Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011. Laryngoscope. 2016. PMID: 27808409. doi:10.1002/lary.26369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。